—
The Avante Ibogaine Institute (avanteibogaine.com) proudly announces the celebration of their 10th year of impactful work as a leading clinical provider of psychedelic-assisted therapies.
Over the last decade, the Avante Ibogaine Institute has been at the forefront of innovative entheogen-based treatment solutions, offering hope and healing to individuals battling addiction, alcoholism, PTSD, and depression. Founder Nic V. Avante credit’s his passion to establish Avante as a beacon of hope in the fight against the worst drug crisis in American history.
“With over 1,500 fentanyl and opioid related overdose deaths occurring each and every week in America, the need for effective treatment solutions has never been more urgent”, said Nic. Avante’s comprehensive range of treatments include clinical ibogaine, psilocybin, MDMA, and 5MeO-DMT therapies.
Comprehensive Treatment Services
Avante’s clinical ibogaine treatment program has been its cornerstone therapy for its ability to interrupt addiction cycles and provide patients with withdrawal-free detox and neurological resets. Avante’s Psilocybin therapy offers patients relief from depression and anxiety, providing new pathways to emotional health and well-being. For those suffering from PTSD and trauma, Avante’s MDMA and 5MeO-DMT therapies have been instrumental in helping individuals reclaim their lives.
A Lifeline for Veterans
One of the standout programs at the Avante Ibogaine Institute is their work with dedicated initiatives aimed at supporting U.S. Military Veterans suffering from post-traumatic stress disorder (PTSD). This program has demonstrated great promise and advances, with Avante’s clinical team developing multiple therapy combinations effective at guiding veterans into relief from post-combat PTSD, depression, and addiction. The success of this program underscores Avante’s commitment to reach a broad range of individuals and provide alternatives to pharmaceutical based therapies that many need to finally achieve sustainable relief from these debilitating conditions.
A Decade of Dedication and A Vision for The Future
Reflecting on the past decade, Nic and the Avante Ibogaine Institute’s dedicated clinical team are filled with gratitude for the opportunities they have had to help transform the lives of thousands of individuals. “We are humbled and remain determined to continue driving our mission forward to defeat addiction, alcoholism, and co-occurring conditions.”
As they look ahead to the next decade, the Avante team is enthusiastic about the future of psychedelic-assisted therapies, the potential for new therapeutic protocol breakthroughs, and the continued support of legislative and domestic legalization initiatives.
“Our journey over the past ten years has been one of growth, education, and advocacy, while maintaining an unwavering commitment to our patients,” said Nic. “It is immensely rewarding to positively impact people’s lives and to finally have society and science take a serious interest in our work and help us continue pushing the boundaries of what is possible in the field of psychedelic-assisted therapies.”
Looking Forward
As the Avante Ibogaine Institute celebrates this significant milestone, the team remains steadfast in their commitment and poised to continue helping lead the way into the next decade of psychedelic-assisted therapies.
For more information about The Avante Ibogaine Institute and its range of therapeutic treatments and programs, please visit avanteibogaine.com or call 1-844-4-AVANTE (1-844-4282683).
About The Avante Ibogaine Institute: The Avante Ibogaine Institute is a leading clinical provider of psychedelic-assisted therapies located in Nassau, Bahamas. Specializing in ibogaine, psilocybin, MDMA, and 5MeO-DMT treatments, the Avante campus offers an inviting oasis resting on three acres of tropical Caribbean splendor. The Avante team are dedicated to helping their patients overcome the most chronic cases of addiction, alcoholism, PTSD, and depression through their innovative and effective psychedelic treatment programs.
Contact Info:
Name: Audria Markel
Email: Send Email
Organization: The Avante Ibogaine Institute
Phone: (242) 804-4402
Website: https://avanteibogaine.com
Release ID: 89136166
In case of encountering any inaccuracies, problems, or queries arising from the content shared in this press release that necessitate action, or if you require assistance with a press release takedown, we urge you to notify us at error@releasecontact.com (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our responsive team will be readily available to promptly address your concerns within 8 hours, resolving any identified issues diligently or guiding you through the necessary steps for removal. The provision of accurate and dependable information is our primary focus.
